A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure.
| Image |  |
|---|---|
| Description | scientific article published on 8 May 2009 |
| Author/s |
author: Yusuke Moritoh |
| Publication date | May 8, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |